SCHEMBL7132014

SCHEMBL7132014

C[C@@H](C(=O)O)[C@@H]1CCc2cc(O)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.55
ESR2 Q92731 7/20 0.55
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
CYP19A1 P11511 2/20 0.43
HSD17B1 P14061 2/20 0.41
AKR1B10 O60218 1/20 0.41
LMNA P02545 1/20 0.41
SHBG P04278 1/20 0.41
CYP1A2 P05177 1/20 0.41
PGR P06401 1/20 0.41
SERPINA6 P08185 1/20 0.41
CYP3A4 P08684 1/20 0.41
STS P08842 1/20 0.41
AR P10275 1/20 0.41
MAPT P10636 1/20 0.41
AKR1B1 P15121 1/20 0.41
NFKB1 P19838 1/20 0.41
SLC6A4 P31645 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231957 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL3020728 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL3018149 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL20214124 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL2358334 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL20214720 1.00 ESR1 (0.55) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL7358263 0.91 ESR1 (0.46) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL3412848 0.88 NQO2 (0.44) ESR1ESR2CYP19A1LMNASLC6A4
SCHEMBL20235166 0.87 ESR1 (0.51) ESR1ESR2PPARGPPARACYP19A1
SCHEMBL28750802 0.87 ESR1 (0.51) ESR1ESR2PPARGPPARACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004011446-A1 INDANE, DIHYDROBENZOFURAN, AND TETRAHYDRONAPHTHALENE CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2004-02-05 WO disclosed